⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
JNJ News
Johnson & Johnson
CAR T-Cell Therapy Market worth $13.78 billion by 2031 | MarketsandMarkets™
prnewswire.com
BMY
GILD
JNJ
CRSP
ALLO
CART
Nucleome Therapeutics appoints experienced biotech executive Dr. Michelle Morrow as Chief Scientific Officer
prnewswire.com
JNJ
PFE
Philadelphia Jury Returns $250,000 Verdict Against J&J in Latest Baby Powder-Ovarian Cancer Trial
businesswire.com
JNJ
STADA and Bio-Thera receive European Marketing Authorization for Gotenfia, a Biosimilar to Simponi
prnewswire.com
JNJ
MEXC and Ondo Finance Expand Tokenized Stock Partnership with 17 New Spot Pairs and Zero-Fee Trading
globenewswire.com
MSFT
JNJ
JPM
BCL-2 Inhibitors Market Poised for Robust Growth During the Forecast Period (2025-2034) as Oncology Pipelines Expand | DelveInsight
prnewswire.com
ABBV
AMGN
AZN
BMY
GILD
JNJ
LLY
MRK
NVS
PFE
SNY
TMO
3 Day Pharma Mini MBA Training Course: Translate Your Learning Into New Behaviours and Improvements (ONLINE EVENT: Mar 18th - Mar 20th, 2026)
globenewswire.com
PFE
MRK
JNJ
GSK
Alzheimer's Therapeutics Market to Reach USD 10.4 Billion by 2036 as Disease-Modifying Immunotherapies Transform Treatment Paradigms
accessnewswire.com
ABBV
BMY
JNJ
LLY
NVS
REGN
BIIB
BioNJ Elects Board Officers and Trustees
prnewswire.com
GMAB
MRK
AMTX
JNJ
ASND
ACAD
BMY
PFE
PTC
NVS
SNY
CLDX
ORYZON Announces Appointment of Rolando Gutierrez-Esteinou, M.D., as Chief Medical Officer for CNS
globenewswire.com
ATAI
JNJ
BMY
NVS